Sorafenib as Adjuvant Therapy Post–Liver Transplant: A Single-center Experience
In this single-center analysis, adjuvant sorafenib was not associated with OS. Recipients were observed to have shorter RFS, likely due to the increased prevalence of high-risk features, and sorafenib use was associated with high frequencies of adverse events.
Authors
- Ahmed Elaileh (ORCID: https://orcid.org/0000-0001-5824-9472)
- Ashton A. Connor (ORCID: https://orcid.org/0000-0002-7596-3771)
- Caroline J. Simon (ORCID: https://orcid.org/0009-0003-0546-439X)
- Tamneet Basra
- R. Mark Ghobrial (ORCID: https://orcid.org/0000-0001-6077-9595)
- Khush Patel (ORCID: https://orcid.org/0000-0002-7451-3103)
- Sudha Kodali (ORCID: https://orcid.org/0000-0002-2816-9647)
- Anaum Maqsood (ORCID: https://orcid.org/0000-0002-6779-594X)
- David W. Victor (ORCID: https://orcid.org/0000-0003-1414-3128)
- Ahmed Omar Kaseb (ORCID: https://orcid.org/0000-0002-9491-0587)
- Mark J. Hobeika (ORCID: https://orcid.org/0000-0002-7444-7097)
- Constance M. Mobley (ORCID: https://orcid.org/0000-0003-3925-4975)
- Hala Hassanain (ORCID: https://orcid.org/0009-0003-0125-3499)
- Elizabeth W. Brombosz (ORCID: https://orcid.org/0000-0002-1734-5959)
- Sadhna Dhingra (ORCID: https://orcid.org/0000-0003-0436-033X)
- A. Osama Gaber
- Ashish Saharia (ORCID: https://orcid.org/0000-0001-5366-8432)
- Jean‐Nicolas Vauthey (ORCID: https://orcid.org/0000-0003-4921-5427)
- Yee Lee Cheah (ORCID: https://orcid.org/0000-0002-6695-4339)
- Maen Abdelrahim (ORCID: https://orcid.org/0000-0002-6631-5035)
- Mary R. Schwartz (ORCID: https://orcid.org/0000-0002-8915-4844)
- Kirk Heyne
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Methodist Hospital (US)
- Methodist Hospital (US)
Publication Details
- Journal
- Transplantation Direct
- Published
- 2025-01-23
- DOI
- https://doi.org/10.1097/txd.0000000000001746
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32
Funders
- American Society of Transplant Surgeons
- Houston Methodist Research Institute